Back to NAGE
D. E. Shaw & Co., Inc. NAGE Position History
Niagen Bioscience, Inc. • Healthcare
Quarters held
11
Latest value
$319K
Q2 2026
Peak value
$23.1M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $112K |
| Q3 2022 | $114K |
| Q4 2022 | $263K |
| Q3 2024 | $196K |
| Q4 2024 | $5.4M |
| Q1 2025 | $8.9M |
| Q2 2025 | $23.1M |
| Q3 2025 | $5.1M |
| Q4 2025 | $2.2M |
| Q1 2026 | $1.2M |
| Q2 2026 | $319K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $319K | 99.9K | — | — |
| Q1 2026 | $1.2M | 277.4K | — | — |
| Q4 2025 | $2.2M | 346.5K | — | — |
| Q3 2025 | $5.1M | 546.2K | — | — |
| Q2 2025 | $23.1M | 1.60M | — | — |
| Q1 2025 | $8.9M | 1.28M | — | — |
| Q4 2024 | $5.4M | 1.01M | — | — |
| Q3 2024 | $196K | 53.6K | — | — |
| Q4 2022 | $263K | 156.4K | — | — |
| Q3 2022 | $114K | 92.5K | — | — |
| Q2 2022 | $112K | 67.3K | — | — |